- info@buhlmannlabs.ch
- +41 61 487 12 12
Anti-C1q antibodies
In the realm of autoimmune diseases, for example systemic lupus erythematosus (SLE), understanding the role of anti-C1q antibodies is pivotal. Our ELISA test is designed to measure anti-C1q antibodies, providing insights into the risk of developing active lupus nephritis. As a simple and efficient diagnostic tool, determination of anti-C1q Antibodies not only aids in excluding the possibility of renal flares in the near future but also serves as a valuable asset for evaluating the effectiveness of immunosuppressive treatments in cases of lupus nephritis.
Anti-C1q antibodies
In the realm of autoimmune diseases, for example systemic lupus erythematosus (SLE), understanding the role of anti-C1q antibodies is pivotal. Our ELISA test is designed to measure anti-C1q antibodies, providing insights into the risk of developing active lupus nephritis. As a simple and efficient diagnostic tool, determination of anti-C1q Antibodies not only aids in excluding the possibility of renal flares in the near future but also serves as a valuable asset for evaluating the effectiveness of immunosuppressive treatments in cases of lupus nephritis.
Anti-C1q autoantibodies can be identified across a broad spectrum of autoimmune diseases, with a particular emphasis on their heightened sensitivity in diagnosing hypocomplementemic urticarial vasculitis.
In systemic lupus erythematosus (SLE), the presence of anti-C1q antibodies is notably linked to proliferative lupus nephritis, and their absence demonstrates a negative predictive value for the development of lupus nephritis, approaching close to 100%.
Anti-C1q Product Information
| Method | ELISA |
| Time to Result | 2h (approx.) |
| Sample Type | 100 µl serum or plasma (1:50) |
| Standard Range | 5-400 Units/ml |
| Cut-off Titer | lower than 15 units/mL should be regarded as negative |
| Order Code | EK-AC1QA |
| Regulatory status | CE according IVDD |
Downloads
EK-AC1QA
* Multilingual [EN, DE, FR, IT, ES]
Social Links